Across behavioral health, dealmaking and investing in 2022 likely won’t reach the remarkable levels seen in 2021. Regardless, there are several reasons to expect that this year will continue to demonstrate that the investment and M&A markets are on the side of behavioral health providers, according to Dexter Braff, the president of the M&A firm The Braff Group.
Even when considering emerging trends and environmental factors tempering dealmaking activity, such as interest rates going up and the threat of an economic recession, the powerful macro-level drivers that lead to 2021’s banner year for behavioral health investment and dealmaking firmly remain in place, reports Behavioral Health Business. Read more.
